# EDGAR Filing Document

**Accession Number:** 0000062234
**File Stem:** 0000062234-25-000037
**Filing Date:** 2025-8
**Character Count:** 143096
**Document Hash:** 064f88ebbb04da2e4db8b6d3b69d047b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000062234-25-000037.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0000062234-25-000037

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 57

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MARCUS CORP
- **CENTRAL INDEX KEY:** 0000062234
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MOTION PICTURE THEATERS [7830]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 391139844
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12604
- **FILM NUMBER:** 251176873

**BUSINESS ADDRESS:**
- **STREET 1:** 111 EAST KILBOURN AVENUE
- **STREET 2:** SUITE 1200
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202-6633
- **BUSINESS PHONE:** 4149051000

**MAIL ADDRESS:**
- **STREET 1:** 111 EAST KILBOURN AVENUE
- **STREET 2:** SUITE 1200
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202-6633

?xml version='1.0' encoding='ASCII'? mcs-20250630

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

(Mark One)

⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended <u>June 30, 2025</u>

□ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number <u>1-12604</u>

---

| |
|:---|
| **THE MARCUS CORPORATION** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| Wisconsin | 39-1139844 |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| 111 East Kilbourn Avenue, Suite 1200<br>Milwaukee ,Wisconsin | 53202-6628 |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: <u>(414) 905-1000</u>

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common Stock, $1.00 par value | MCS | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.

 Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act (Check One).

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | □ | Accelerated filer | ⌧ |
| Non-accelerated filer | □ | Smaller reporting company | □ |
| | | Emerging growth company | □ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 Yes □ No ⌧

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

COMMON STOCK OUTSTANDING AT JULY 29, 2025 – 24,326,492

CLASS B COMMON STOCK OUTSTANDING AT JULY 29, 2025 –6,984,584

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**<u>THE MARCUS CORPORATION</u>**

**<u>INDEX</u>**

---

| | | |
|:---|:---|:---|
| | | Page |
| **<u>[PART I – FINANCIAL INFORMATION](#ie4db6407dc034a498daea3bed427a42e_10)</u>** | **<u>[PART I – FINANCIAL INFORMATION](#ie4db6407dc034a498daea3bed427a42e_10)</u>** |  |
| <u>[Item 1.](#ie4db6407dc034a498daea3bed427a42e_13)</u> | <u>[Consolidated Financial Statements (Unaudited):](#ie4db6407dc034a498daea3bed427a42e_13)</u> |  |
|  | <u>[Consolidated Balance Sheets](#ie4db6407dc034a498daea3bed427a42e_16)</u> | [3](#ie4db6407dc034a498daea3bed427a42e_16) |
|  | <u>[Consolidated Statements of Operations](#ie4db6407dc034a498daea3bed427a42e_19)</u> | [5](#ie4db6407dc034a498daea3bed427a42e_19) |
|  | <u>[Consolidated Statements of Comprehensive Income (Loss)](#ie4db6407dc034a498daea3bed427a42e_22)</u> | [6](#ie4db6407dc034a498daea3bed427a42e_22) |
|  | <u>[Consolidated Statements of Cash Flows](#ie4db6407dc034a498daea3bed427a42e_25)</u> | [7](#ie4db6407dc034a498daea3bed427a42e_25) |
|  | <u>[Condensed Notes to Consolidated Financial Statements](#ie4db6407dc034a498daea3bed427a42e_28)</u> | [8](#ie4db6407dc034a498daea3bed427a42e_28) |
| <u>[Item 2.](#ie4db6407dc034a498daea3bed427a42e_58)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ie4db6407dc034a498daea3bed427a42e_58)</u> | [15](#ie4db6407dc034a498daea3bed427a42e_58) |
| <u>[Item 3.](#ie4db6407dc034a498daea3bed427a42e_82)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#ie4db6407dc034a498daea3bed427a42e_82)</u> | [26](#ie4db6407dc034a498daea3bed427a42e_82) |
| <u>[Item 4.](#ie4db6407dc034a498daea3bed427a42e_85)</u> | <u>[Controls and Procedures](#ie4db6407dc034a498daea3bed427a42e_85)</u> | [26](#ie4db6407dc034a498daea3bed427a42e_85) |
| **<u>[PART II – OTHER INFORMATION](#ie4db6407dc034a498daea3bed427a42e_88)</u>** | **<u>[PART II – OTHER INFORMATION](#ie4db6407dc034a498daea3bed427a42e_88)</u>** |  |
| <u>[Item 1A.](#ie4db6407dc034a498daea3bed427a42e_91)</u> | <u>[Risk Factors](#ie4db6407dc034a498daea3bed427a42e_91)</u> | [27](#ie4db6407dc034a498daea3bed427a42e_91) |
| <u>[Item 2.](#ie4db6407dc034a498daea3bed427a42e_94)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ie4db6407dc034a498daea3bed427a42e_94)</u> | [27](#ie4db6407dc034a498daea3bed427a42e_94) |
| <u>[Item 4.](#ie4db6407dc034a498daea3bed427a42e_97)</u> | <u>[Mine Safety Disclosures](#ie4db6407dc034a498daea3bed427a42e_97)</u> | [28](#ie4db6407dc034a498daea3bed427a42e_97) |
| <u>[Item 5.](#ie4db6407dc034a498daea3bed427a42e_100)</u> | <u>[Other Information](#ie4db6407dc034a498daea3bed427a42e_100)</u> | [28](#ie4db6407dc034a498daea3bed427a42e_100) |
| <u>[Item 6.](#ie4db6407dc034a498daea3bed427a42e_103)</u> | <u>[Exhibits](#ie4db6407dc034a498daea3bed427a42e_103)</u> | [28](#ie4db6407dc034a498daea3bed427a42e_103) |
|  | <u>[Signatures](#ie4db6407dc034a498daea3bed427a42e_106)</u> | S-[1](#ie4db6407dc034a498daea3bed427a42e_106) |

---

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**PART I – FINANCIAL INFORMATION**

**Item 1. Consolidated Financial Statements**

**THE MARCUS CORPORATION**

**Consolidated Balance Sheets**

*(in thousands, except share and per share data)*

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | **December 26,<br>2024** |
| **ASSETS** | | |
| **Current assets:** | | |
| &nbsp;&nbsp;Cash and cash equivalents | $14901 | $40841 |
| &nbsp;&nbsp;Restricted cash | 1798 | 3738 |
| &nbsp;&nbsp;Accounts receivable, net of reserves of $225 and $141, respectively | 22724 | 21457 |
| &nbsp;&nbsp;Assets held for sale |  | 1199 |
| &nbsp;&nbsp;Other current assets | 21586 | 24915 |
| Total current assets | 61009 | 92150 |
| **Property and equipment:** |  |  |
| &nbsp;&nbsp;Land and improvements | 135582 | 129991 |
| &nbsp;&nbsp;Buildings and improvements | 738666 | 736408 |
| &nbsp;&nbsp;Leasehold improvements | 164742 | 166149 |
| &nbsp;&nbsp;Furniture, fixtures and equipment | 430014 | 424807 |
| &nbsp;&nbsp;Finance lease right-of-use assets | 30407 | 29061 |
| &nbsp;&nbsp;Construction in progress | 40380 | 15590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total property and equipment | 1539791 | 1502006 |
| &nbsp;&nbsp;Less accumulated depreciation and amortization | 845552 | 816272 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property and equipment | 694239 | 685734 |
| **Operating lease right-of-use assets** | 152686 | 159194 |
| **Other assets:** |  |  |
| &nbsp;&nbsp;Investments in joint ventures | 4603 | 5166 |
| &nbsp;&nbsp;Goodwill | 74996 | 74996 |
| &nbsp;&nbsp;Deferred incomes taxes | 5896 | 3956 |
| &nbsp;&nbsp;Other | 22878 | 23332 |
| Total other assets | 108373 | 107450 |
| **TOTAL ASSETS** | $1016307 | $1044528 |

---

See accompanying condensed notes to consolidated financial statements.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**Consolidated Balance Sheets**

*(in thousands, except share and per share data)*

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | **December 26,<br>2024** |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** | | |
| **Current liabilities:** | | |
| &nbsp;&nbsp;Accounts payable | $36675 | $50690 |
| &nbsp;&nbsp;Income taxes | 1050 |  |
| &nbsp;&nbsp;Taxes other than income taxes | 18512 | 18696 |
| &nbsp;&nbsp;Accrued compensation | 16743 | 24976 |
| &nbsp;&nbsp;Other accrued liabilities | 54930 | 53830 |
| &nbsp;&nbsp;Current portion of finance lease obligations | 2785 | 2591 |
| &nbsp;&nbsp;Current portion of operating lease obligations | 16062 | 15765 |
| &nbsp;&nbsp;Current maturities of long-term debt | 9772 | 10133 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 156529 | 176681 |
| **Finance lease obligations** | 9572 | 10360 |
| **Operating lease obligations** | 156754 | 164776 |
| **Long-term debt** | 170116 | 149007 |
| **Deferred income taxes** | 28686 | 32619 |
| **Other long-term obligations** | 46232 | 46219 |
| **Shareholders' Equity:** |  |  |
| &nbsp;&nbsp;Preferred Stock, $1 par; authorized 1,000,000 shares; none issued |  |  |
| &nbsp;&nbsp;Common Stock, $1 par; authorized 50,000,000 shares; issued 25,369,054 shares at June 30, 2025 and 25,237,374 shares at December 26, 2024 | 25369 | 25237 |
| &nbsp;&nbsp;Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 6,984,584 shares at June 30, 2025 and 6,984,584 shares at December 26, 2024 | 6985 | 6985 |
| &nbsp;&nbsp;Capital in excess of par | 181688 | 177172 |
| &nbsp;&nbsp;Retained earnings | 251204 | 265028 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | (189) | (181) |
|  | 465057 | 474241 |
| &nbsp;&nbsp;Less cost of Common Stock in treasury (1,042,655 shares at June 30, 2025 and 604,914 shares at December 26, 2024) | (16639) | (9375) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 448418 | 464866 |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | $1016307 | $1044528 |

---

See accompanying condensed notes to consolidated financial statements.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**Consolidated Statements of Operations**

*(in thousands, except per share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,<br>2025** | **June 27,<br>2024** | **June 30,<br>2025** | **June 27,<br>2024** |
| **Revenues:** | | | | |
| &nbsp;&nbsp;Theatre admissions | $62348 | $48580 | $103279 | $89176 |
| &nbsp;&nbsp;Rooms | 29632 | 30496 | 48907 | 48709 |
| &nbsp;&nbsp;Theatre concessions | 57611 | 44417 | 95611 | 79112 |
| &nbsp;&nbsp;Food and beverage | 21291 | 19272 | 39120 | 35435 |
| &nbsp;&nbsp;Other revenues | 24790 | 22534 | 47664 | 42236 |
|  | 195672 | 165299 | 334581 | 294668 |
| &nbsp;&nbsp;Cost reimbursements | 10371 | 10733 | 20228 | 19911 |
| Total revenues | 206043 | 176032 | 354809 | 314579 |
| **Costs and expenses:** |  |  |  |  |
| &nbsp;&nbsp;Theatre operations | 64172 | 52118 | 113842 | 97103 |
| &nbsp;&nbsp;Rooms | 11086 | 11164 | 20992 | 20575 |
| &nbsp;&nbsp;Theatre concessions | 23337 | 18515 | 40788 | 33401 |
| &nbsp;&nbsp;Food and beverage | 15656 | 15080 | 30285 | 28943 |
| &nbsp;&nbsp;Advertising and marketing | 6644 | 6502 | 11888 | 11803 |
| &nbsp;&nbsp;Administrative | 22972 | 22630 | 47688 | 44032 |
| &nbsp;&nbsp;Depreciation and amortization | 17603 | 16699 | 35441 | 32714 |
| &nbsp;&nbsp;Rent | 6354 | 6496 | 12571 | 12843 |
| &nbsp;&nbsp;Property taxes | 4328 | 3688 | 8737 | 7619 |
| &nbsp;&nbsp;Other operating expenses | 10332 | 9741 | 20938 | 19611 |
| &nbsp;&nbsp;(Gain) loss on disposition of property, equipment and other assets | 181 | (43) | (1184) | (20) |
| &nbsp;&nbsp;Impairment charges |  | 472 |  | 472 |
| &nbsp;&nbsp;Reimbursed costs | 10371 | 10733 | 20228 | 19911 |
| Total costs and expenses | 193036 | 173795 | 362214 | 329007 |
| **Operating income (loss)** | 13007 | 2237 | (7405) | (14428) |
| **Other income (expense):** |  |  |  |  |
| &nbsp;&nbsp;Investment income | 409 | 173 | 483 | 865 |
| &nbsp;&nbsp;Interest expense | (2981) | (2564) | (5803) | (5098) |
| &nbsp;&nbsp;Other income (expense) | (443) | (390) | (887) | (731) |
| &nbsp;&nbsp;Debt conversion expense |  | (13908) |  | (13908) |
| &nbsp;&nbsp;Equity earnings (losses) from unconsolidated joint ventures | 75 | (50) | (495) | (437) |
|  | (2940) | (16739) | (6702) | (19309) |
| **Earnings (loss) before income taxes** | 10067 | (14502) | (14107) | (33737) |
| **Income tax expense (benefit)** | 2746 | 5719 | (4612) | (1650) |
| **Net earnings (loss)** | $7321 | $(20221) | $(9495) | $(32087) |
| **Net earnings (loss) per share - basic:** |  |  |  |  |
| &nbsp;&nbsp;Common Stock | $0.24 | $(0.64) | $(0.31) | $(1.03) |
| &nbsp;&nbsp;Class B Common Stock | $0.22 | $(0.58) | $(0.28) | $(0.92) |
| **Net earnings (loss) per share - diluted:** |  |  |  |  |
| &nbsp;&nbsp;Common Stock | $0.23 | $(0.64) | $(0.31) | $(1.03) |
| &nbsp;&nbsp;Class B Common Stock | $0.22 | $(0.58) | $(0.28) | $(0.92) |

---

See accompanying condensed notes to consolidated financial statements.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**Consolidated Statements of Comprehensive Income (Loss)**

*(in thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,<br>2025** | **June 27,<br>2024** | **June 30,<br>2025** | **June 27,<br>2024** |
| **Net earnings (loss)** | $7321 | $(20221) | $(9495) | $(32087) |
| **Other comprehensive loss, net of tax:** |  |  |  |  |
| Amortization of the net actuarial loss and prior service credit related to the pension, net of tax benefit of $1, $5, $3 and $9, respectively | (4) | (11) | (8) | (23) |
| **Other comprehensive loss** | (4) | (11) | (8) | (23) |
| **Comprehensive earnings (loss)** | $7317 | $(20232) | $(9503) | $(32110) |

---

See accompanying condensed notes to consolidated financial statements.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**Consolidated Statements of Cash Flows**

*(in thousands)*

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **June 30, 2025** | **June 27, 2024** |
| **OPERATING ACTIVITIES:** | | |
| Net loss | $(9495) | $(32087) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;Losses on investments in joint ventures | 495 | 437 |
| &nbsp;&nbsp;Distribution from joint venture | 68 |  |
| &nbsp;&nbsp;Gain on disposition of property, equipment and other assets | (1184) | (20) |
| &nbsp;&nbsp;Impairment charges |  | 472 |
| &nbsp;&nbsp;Debt conversion expense |  | 13908 |
| &nbsp;&nbsp;Depreciation and amortization | 35441 | 32714 |
| &nbsp;&nbsp;Amortization of debt issuance costs | 314 | 708 |
| &nbsp;&nbsp;Share-based compensation | 4986 | 4932 |
| &nbsp;&nbsp;Deferred income taxes | (5870) | (2077) |
| &nbsp;&nbsp;Other long-term obligations | 181 | 555 |
| &nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (1267) | (747) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | (6437) | 1093 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | (1053) | (314) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (13679) | 5704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | 1132 | 240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes other than income taxes | (204) | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | (8233) | (3424) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued liabilities | 1116 | (1267) |
| Total adjustments | 5806 | 52964 |
| **Net cash provided by (used in) operating activities** | (3689) | 20877 |
| **INVESTING ACTIVITIES:** |  |  |
| Capital expenditures | (39915) | (35283) |
| Proceeds from disposals of property, equipment and other assets | 212 | 71 |
| Capital contribution in joint venture |  | (5620) |
| Subscription and sale of joint venture interests |  | 1500 |
| Proceeds from sale of trading securities | 8187 | 37 |
| Purchase of trading securities |  | (1148) |
| Other investing activities | (29) | (197) |
| **Net cash used in investing activities** | (31545) | (40640) |
| **FINANCING ACTIVITIES:** |  |  |
| Debt transactions: |  |  |
| &nbsp;&nbsp;Proceeds from borrowings on revolving credit facility | 105000 | 81000 |
| &nbsp;&nbsp;Repayment of borrowings on revolving credit facility | (84000) | (36000) |
| &nbsp;&nbsp;Principal payments on long-term debt | (392) | (681) |
| &nbsp;&nbsp;Repurchase of convertible senior notes |  | (46481) |
| &nbsp;&nbsp;Proceeds from capped call unwind |  | 5770 |
| &nbsp;&nbsp;Principal payments on finance lease obligations | (1323) | (1214) |
| Equity transactions: |  |  |
| &nbsp;&nbsp;Treasury stock transactions, except for stock options | (7612) | (265) |
| &nbsp;&nbsp;Exercise of stock options | 10 |  |
| &nbsp;&nbsp;Dividends paid | (4329) | (4419) |
| **Net cash provided by (used in) financing activities** | 7354 | (2290) |
| Net decrease in cash, cash equivalents and restricted cash | (27880) | (22053) |
| Cash, cash equivalents and restricted cash at beginning of period | 44579 | 59838 |
| **Cash, cash equivalents and restricted cash at end of period** | $16699 | $37785 |
| Supplemental Information: |  |  |
| &nbsp;&nbsp;Interest paid, net of amounts capitalized | $5356 | $5643 |
| &nbsp;&nbsp;Income taxes paid | 125 | 188 |
| &nbsp;&nbsp;Change in accounts payable for additions to property, equipment and other assets | (336) | 4716 |

---

See accompanying condensed notes to consolidated financial statements.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

**1. General**

**Basis of Presentation** - The unaudited consolidated financial statements for the three and six months ended June 30, 2025 and June 27, 2024 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 30, 2025, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 26, 2024.

Beginning on December 27, 2024, the Company's fiscal year changed from a 52- or 53-week fiscal year ending on the last Thursday in December of each year to a fiscal year ending on December 31 of each year. Accordingly, effective for its fiscal year ending December 31, 2025, the Company's quarterly results will be for three month periods ending March 31, June 30, September 30 and December 31 of each year. In this quarterly report, the three and six months ended June 30, 2025 refer to the periods April 1, 2025 through June 30, 2025 and December 27, 2024 through June 30, 2025, respectively, and the three and six months ended June 27, 2024 refer to the periods March 29, 2024 through June 27, 2024 and December 29, 2023 through June 27, 2024, respectively.

**Accounting Policies** - Refer to the Company's audited consolidated financial statements (including footnotes) for the fiscal year ended December 26, 2024, contained in the Company's Annual Report on Form 10-K for such year, for a description of the Company's accounting policies.

**Depreciation and Amortization** - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $17,597 and $35,428, respectively, for the three and six months ended June 30, 2025, and $16,701 and $32,715, respectively, for the three and six months ended ended June 27, 2024.

**Assets Held for Sale** – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset.

**Long-Lived Assets** – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value.

During the three months ended June 27, 2024, the Company determined that indicators of impairment were present at one asset group for a leased theatre location in which the Company made the decision to close during the second quarter of fiscal 2024. As such, the Company evaluated the fair value of these assets, consisting primarily of land improvements, leasehold improvements, building, furniture, fixtures and equipment, and operating lease right-of-use assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset), was less than their carrying values and recorded a $472 impairment loss, reducing certain property and equipment and certain operating lease net obligations. The remaining net book value of the impaired assets as of the date of the asset write-down (June 27, 2024) was $0. There were no indicators of impairment identified during the six months ended June 30, 2025.

**Goodwill** – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the six months ended June 30, 2025 or June 27, 2024.

**Earnings (Loss) Per Share** - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options, restricted stock units, performance stock units and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30, 2025** | **June 27, 2024** | **June 30, 2025** | **June 27, 2024** |
| Net earnings (loss) per share - basic: |  |  |  |  |
| &nbsp;&nbsp;Common Stock | $0.24 | $(0.64) | $(0.31) | $(1.03) |
| &nbsp;&nbsp;Class B Common Stock | $0.22 | $(0.58) | $(0.28) | $(0.92) |
| Net earnings (loss) per share - diluted: |  |  |  |  |
| &nbsp;&nbsp;Common Stock | $0.23 | $(0.64) | $(0.31) | $(1.03) |
| &nbsp;&nbsp;Class B Common Stock | $0.22 | $(0.58) | $(0.28) | $(0.92) |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;Net earnings (loss) | $7321 | $(20221) | $(9495) | $(32087) |
| Denominator (in thousands): |  |  |  |  |
| &nbsp;&nbsp;Denominator for basic EPS | 31304 | 32161 | 31453 | 32027 |
| &nbsp;&nbsp;Effect of dilutive employee stock options | 47 |  |  |  |
| &nbsp;&nbsp;Effect of restricted stock units | 80 |  |  |  |
| &nbsp;&nbsp;Effect of convertible senior notes |  |  |  |  |
| &nbsp;&nbsp;Diluted weighted-average shares outstanding | 31431 | 32161 | 31453 | 32027 |
| Weighted-average number of anti-dilutive shares excluded from denominator (in thousands): |  |  |  |  |
| &nbsp;&nbsp;Employee stock options | 2215 | 3146 | 1829 | 2934 |
| &nbsp;&nbsp;Restricted stock units |  | 50 | 72 | 50 |
| &nbsp;&nbsp;Performance stock units | 238 | 143 | 213 | 143 |
| &nbsp;&nbsp;Convertible senior notes |  | 6719 |  | 8009 |
| Total | 2452 | 10058 | 2114 | 11136 |

---

For the periods when the Company reports a net loss, common stock equivalents, restricted stock units, performance stock units, and shares related to the convertible senior notes are excluded from the computation of diluted loss per share as their inclusion would have an anti-dilutive effect. Performance stock units are considered anti-dilutive if the performance targets upon which the issuance of the shares are contingent have not been achieved and the respective performance period has not been completed as of the end of the current period. Shares related to the convertible senior notes were excluded from the computation of diluted earnings per share in periods when the effect would have been anti-dilutive using the if-converted method.

**Shareholders' Equity** - Activity impacting total shareholders' equity for the six months ended June 30, 2025 and June 27, 2024 was as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common <br>Stock** | **Class B <br>Common <br>Stock** | **Capital <br>in Excess <br>of Par** | **Retained <br>Earnings** | **Accumulated <br>Other <br>Comprehensive<br>Loss** | **Treasury <br>Stock** | **Total Shareholders' <br>Equity** |
| BALANCES AT DECEMBER 26, 2024 | $25237 | $6985 | $177172 | $265028 | $(181) | $(9375) | $464866 |
| &nbsp;&nbsp;Cash dividends: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;$0.064 per share Class B Common Stock |  |  |  | (447) |  |  | (447) |
| &nbsp;&nbsp;&nbsp;$0.07 per share Common Stock |  |  |  | (1733) |  |  | (1733) |
| &nbsp;&nbsp;Exercise of stock options |  |  | 1 |  |  | 7 | 8 |
| &nbsp;&nbsp;Purchase of treasury stock |  |  |  |  |  | (7642) | (7642) |
| &nbsp;&nbsp;Reissuance of treasury stock |  |  | 1 |  |  | 13 | 14 |
| &nbsp;&nbsp;Issuance of non-vested stock | 132 |  | (208) |  |  | 76 |  |
| &nbsp;&nbsp;Shared-based compensation |  |  | 3545 |  |  |  | 3545 |
| &nbsp;&nbsp;Other |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Conversions of Class B Common Stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Comprehensive loss |  |  |  | (16816) | (4) |  | (16820) |
| BALANCES AT MARCH 31, 2025 | 25369 | 6985 | 180511 | 246032 | (185) | (16921) | 441791 |
| &nbsp;&nbsp;Cash dividends: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;$0.064 per share Class B Common Stock |  |  |  | (447) |  |  | (447) |
| &nbsp;&nbsp;&nbsp;$0.07 per share Common Stock |  |  |  | (1702) |  |  | (1702) |
| &nbsp;&nbsp;Exercise of stock options |  |  |  |  |  | 2 | 2 |
| &nbsp;&nbsp;Purchase of treasury stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Reissuance of treasury stock |  |  | 1 |  |  | 15 | 16 |
| &nbsp;&nbsp;Issuance of non-vested stock |  |  | (265) |  |  | 265 |  |
| &nbsp;&nbsp;Shared-based compensation |  |  | 1441 |  |  |  | 1441 |
| &nbsp;&nbsp;Other |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Conversions of Class B Common Stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Comprehensive loss |  |  |  | 7321 | (4) |  | 7317 |
| BALANCES AT JUNE 30, 2025 | $25369 | $6985 | $181688 | $251204 | $(189) | $(16639) | $448418 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common <br>Stock** | **Class B <br>Common <br>Stock** | **Capital <br>in Excess <br>of Par** | **Retained <br>Earnings** | **Accumulated <br>Other <br>Comprehensive<br>Loss** | **Treasury <br>Stock** | **Total Shareholders' <br>Equity** |
| BALANCES AT DECEMBER 28, 2023 | $24692 | $7078 | $160642 | $281599 | $(1336) | $(1503) | $471172 |
| &nbsp;&nbsp;Cash dividends: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;$0.064 per share Class B Common Stock |  |  |  | (449) |  |  | (449) |
| &nbsp;&nbsp;&nbsp;$0.07 per share Common Stock |  |  |  | (1760) |  |  | (1760) |
| &nbsp;&nbsp;Purchase of treasury stock |  |  |  |  |  | (301) | (301) |
| &nbsp;&nbsp;Reissuance of treasury stock |  |  | (3) |  |  | 23 | 20 |
| &nbsp;&nbsp;Issuance of non-vested stock | 452 |  | (515) |  |  | 63 |  |
| &nbsp;&nbsp;Shared-based compensation |  |  | 2514 |  |  |  | 2514 |
| &nbsp;&nbsp;Conversions of Class B Common Stock | 93 | (93) |  |  |  |  |  |
| &nbsp;&nbsp;Comprehensive loss |  |  |  | (11866) | (12) |  | (11878) |
| BALANCES AT MARCH 28, 2024 | 25237 | 6985 | 162638 | 267524 | (1348) | (1718) | 459318 |
| &nbsp;&nbsp;Cash dividends: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;$0.064 per share Class B Common Stock |  |  |  | (447) |  |  | (447) |
| &nbsp;&nbsp;&nbsp;$0.070 per share Common Stock |  |  |  | (1763) |  |  | (1763) |
| &nbsp;&nbsp;Reissuance of treasury stock |  |  | (7) |  |  | 23 | 16 |
| &nbsp;&nbsp;Issuance of non-vested stock |  |  | (326) |  |  | 326 |  |
| &nbsp;&nbsp;Shared-based compensation |  |  | 2418 |  |  |  | 2418 |
| &nbsp;&nbsp;Convertible senior note repurchase |  |  | (2788) |  |  |  | (2788) |
| &nbsp;&nbsp;Capped call unwind |  |  | 12904 |  |  |  | 12904 |
| &nbsp;&nbsp;Comprehensive loss |  |  |  | (20221) | (11) |  | (20232) |
| BALANCES AT JUNE 27, 2024 | $25237 | $6985 | $174839 | $245093 | $(1359) | $(1369) | $449426 |

---

**Accumulated Other Comprehensive Loss** – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | **December 26,<br>2024** |
| Net unrecognized actuarial loss for pension obligation | $(189) | $(181) |
|  | $(189) | $(181) |

---

**Fair Value Measurements** - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company's assets and liabilities measured at fair value are classified in one of the following categories:

*<u>Level 1</u>* - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 30, 2025 and December 26, 2024, the Company's $0 and $8,142, respectively, of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 30, 2025 and December 26, 2024, the Company had $0 and $19,002, respectively, of investments in money market funds which were valued using Level 1 pricing inputs and were included in cash and cash equivalents.

*<u>Level 2</u>* - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At each of June 30, 2025 and December 26, 2024, none of the Company's recorded assets or liabilities were measured using Level 2 pricing inputs.

*<u>Level 3</u>* - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At each of June 30, 2025 and December 26, 2024, none of the Company's recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets that are measured on a non-recurring basis are discussed above under *Long-Lived Assets*.

The carrying value of the Company's financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company's $160,000 of senior notes, valued using Level 2 pricing inputs, is approximately $164,119 at June 30, 2025, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The carrying amounts of the Company's remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.

**Defined Benefit Plan** - The components of the net periodic pension cost of the Company's unfunded nonqualified, defined-benefit plan are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30, 2025** | **June 27, 2024** | **June 30, 2025** | **June 27, 2024** |
| Service cost | $50 | $62 | $100 | $124 |
| Interest cost | 463 | 445 | 927 | 889 |
| Net amortization of prior service cost and actuarial loss | (5) | (16) | (11) | (32) |
| Net periodic pension cost | $508 | $491 | $1016 | $981 |

---

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of operations.

**Revenue Recognition** – The disaggregation of revenues by business segment for the three and six months ended June 30, 2025 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** |
| | **Theatres** | **Hotels/Resorts** | **Corporate** | **Total** |
| Theatre admissions | $62348 | $— | $— | $62348 |
| Rooms |  | 29632 |  | 29632 |
| Theatre concessions | 57611 |  |  | 57611 |
| Food and beverage |  | 21291 |  | 21291 |
| Other revenues<sup>(1)</sup> | 11045 | 13634 | 111 | 24790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue before cost reimbursements | 131004 | 64557 | 111 | 195672 |
| Cost reimbursements | 646 | 9725 |  | 10371 |
| Total revenues | $131650 | $74282 | $111 | $206043 |
|  | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
|  | **Theatres** | **Hotels/Resorts** | **Corporate** | **Total** |
| Theatre admissions | $103279 | $— | $— | $103279 |
| Rooms |  | 48907 |  | 48907 |
| Theatre concessions | 95611 |  |  | 95611 |
| Food and beverage |  | 39120 |  | 39120 |
| Other revenues<sup>(1)</sup> | 18636 | 28830 | 198 | 47664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue before cost reimbursements | 217526 | 116857 | 198 | 334581 |
| Cost reimbursements | 1481 | 18747 |  | 20228 |
| Total revenues | $219007 | $135604 | $198 | $354809 |

---

<sup>(1)</sup> Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the three and six months ended June 27, 2024 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** |
| | **Theatres** | **Hotels/Resorts** | **Corporate** | **Total** |
| Theatre admissions | $48580 | $— | $— | $48580 |
| Rooms |  | 30496 |  | 30496 |
| Theatre concessions | 44417 |  |  | 44417 |
| Food and beverage |  | 19272 |  | 19272 |
| Other revenues<sup>(1)</sup> | 8455 | 13996 | 83 | 22534 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue before cost reimbursements | 101452 | 63764 | 83 | 165299 |
| Cost reimbursements |  | 10733 |  | 10733 |
| Total revenues | $101452 | $74497 | $83 | $176032 |
|  | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** |
|  | **Theatres** | **Hotels/Resorts** | **Corporate** | **Total** |
| Theatre admissions | $89176 | $— | $— | $89176 |
| Rooms |  | 48709 |  | 48709 |
| Theatre concessions | 79112 |  |  | 79112 |
| Food and beverage |  | 35435 |  | 35435 |
| Other revenues<sup>(1)</sup> | 14434 | 27639 | 163 | 42236 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue before cost reimbursements | 182722 | 111783 | 163 | 294668 |
| Cost reimbursements |  | 19911 |  | 19911 |
| Total revenues | $182722 | $131694 | $163 | $314579 |

---

<sup>(1)</sup> Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of $37,451 and $36,353 as of June 30, 2025 and December 26, 2024, respectively. The Company had no contract assets as of June 30, 2025 and December 26, 2024. During the six months ended June 30, 2025, the Company recognized revenue of $12,448 that was included in deferred revenues as of December 26, 2024. During the six months ended June 27, 2024, the Company recognized revenue of $12,789 that was included in deferred revenues as of December 28, 2023. The majority of the Company's deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company's loyalty program.

As of June 30, 2025, the amount of transaction price allocated to the remaining performance obligations under the Company's advanced ticket sales was $1,786 and is reflected in the Company's consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of June 30, 2025, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $13,081 and is reflected in the Company's consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.

As of June 30, 2025, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,453 and is reflected in the Company's consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company's revenue is recognized in less than one year from the original contract.

**Recent Accounting Pronouncements** - In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, *Income Taxes (Topic 740: Improvements to Income Tax Disclosures (ASU No. 2023-09*). ASU No. 2023-09 requires on an annual basis specific category disclosures in the rate reconciliation, additional information for reconciling items that meet a quantitative threshold within the rate reconciliation, and additional disclosures related to income taxes paid. ASU No. 2023-09 is effective for the Company in fiscal 2025 and must be applied prospectively with retrospective application permitted. The Company is evaluating the impact that ASU No. 2023-09 will have on its consolidated financial statement disclosures.

On November 4, 2024, the FASB issued ASU No. 2024-03, *Disaggregation of Income Statement Expenses (DISE),* which requires disaggregated disclosure of income statement expenses for public business entities. ASU No. 2024-03 does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU No. 2024-03 is effective for the Company in fiscal 2027. The Company is evaluating the effect the guidance will have on its consolidated financial statement disclosures.

In fiscal 2024, the Company adopted ASU No. 2023-07, *Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU No. 2023-07)*, which requires disclosure of incremental segment information on an annual and interim basis. The annual requirements of ASU No. 2023-07 were included in the Company's fiscal 2024 Annual Report Business Segment footnote (Note 13) and the interim requirements of ASU No. 2023-07 are included in Note 7 of this quarterly report. The adoption of the new standard did not have a material effect on the Company's consolidated financial statements.

**2. Long-Term Debt** 

Long-term debt is summarized as follows:

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 26, 2024** |
| Senior notes | $160000 | $160000 |
| Revolving credit agreement | 21000 |  |
| Other debt |  | 392 |
| &nbsp;&nbsp;Total debt | 181000 | 160392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt issuance costs | (1112) | (1252) |
| &nbsp;&nbsp;Total debt, net of debt issuance costs | 179888 | 159140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less current maturities, net of issuance costs | 9772 | 10133 |
| Long-term debt | $170116 | $149007 |

---

*Credit Agreement*

As of June 30, 2025, the Company has a Credit Agreement that provides for a revolving credit facility that matures on October 16, 2028 with an initial maximum aggregate amount of availability of $225,000. At June 30, 2025, there were borrowings of $21,000 outstanding on the revolving credit facility, which when borrowed, bear interest at the secured overnight financing rate (SOFR) plus a margin (as discussed further below), approximately 6.07% at June 30, 2025. Availability under the $225,000 revolving credit facility was $199,165 as of June 30, 2025 after taking into consideration outstanding letters of credit that reduce revolver availability.

Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) the term SOFR, plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon the Company's net leverage ratio as of the most recent determination date, or (ii) the alternate base rate ("ABR") (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon the Company's net leverage ratio as of the most recent determination date. The revolving credit facility also requires an annual facility fee equal to 0.175% to 0.275% of the total revolving commitments depending on the Company's consolidated net leverage ratio.

The Credit Agreement includes, among other restrictions and covenants applicable to the Company, a requirement that the Company's consolidated net leverage ratio not exceed 3.50:1.00, provided that, with some limitations, such ratio may be increased to 4.00:1:00 for the full fiscal quarter in which a material acquisition (in which aggregate consideration equals or exceeds $30,000) is consummated and the three fiscal quarters immediately thereafter, and a requirement that the Company's interest coverage ratio at the end of any fiscal quarter not be less than 3.00:1.00.

In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company's subsidiaries have guaranteed the Company's obligations under the Credit Agreement.

The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.

*Note Purchase Agreements*

At June 30, 2025, the Company's $160,000 of senior notes consisted of two Note Purchase Agreements and one Master Note Purchase Agreement (collectively the "Senior Notes Agreements") maturing in 2025 through 2034, which require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 7.02%. The weighted average fixed rate of the $160,000 senior notes was 5.94% as of June 30, 2025.

**3. Leases**

The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to Accounting Standards Codification No. 842, *Leases*. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.

The majority of the Company's lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company's performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

Total lease cost consists of the following:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| **Lease Cost** | **Classification** | **June 30, 2025** | **June 27, 2024** | **June 30, 2025** | **June 27, 2024** |
| Finance lease costs: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of finance lease assets | Depreciation and amortization | $602 | $554 | $1152 | $1169 |
| &nbsp;&nbsp;Interest on lease liabilities | Interest expense | 152 | 160 | 302 | 335 |
|  |  | $754 | $714 | $1454 | $1504 |
| Operating lease costs: |  |  |  |  |  |
| &nbsp;&nbsp;Operating lease costs | Rent expense | $5759 | $6133 | $11528 | $12118 |
| &nbsp;&nbsp;Variable lease cost | Rent expense | 544 | 290 | 947 | 602 |
| &nbsp;&nbsp;Short-term lease cost | Rent expense | 51 | 73 | 96 | 123 |
|  |  | $6354 | $6496 | $12571 | $12843 |

---

Additional information related to leases is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>**Other Information** | **June 30, 2025** | **June 27, 2024** | **June 30, 2025** | **June 27, 2024** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |
| &nbsp;&nbsp;Financing cash flows from finance leases | $683 | $613 | $1323 | $1214 |
| &nbsp;&nbsp;Operating cash flows from finance leases | 152 | 160 | 302 | 335 |
| &nbsp;&nbsp;Operating cash flows from operating leases | 6359 | 6527 | 12804 | 12809 |
| Right of use assets obtained in exchange for new lease obligations: |  |  |  |  |
| &nbsp;&nbsp;Finance lease liabilities | 632 | 115 | 757 | 115 |
| &nbsp;&nbsp;Operating lease liabilities |  | 2112 | 1261 | 2112 |

---

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 26, 2024** |
| Finance leases: |  |  |
| &nbsp;&nbsp;Property and equipment – gross | $30407 | $29061 |
| &nbsp;&nbsp;Accumulated depreciation and amortization | (20189) | (19078) |
| &nbsp;&nbsp;Property and equipment - net | $10218 | $9983 |

---

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

Remaining lease terms and discount rates are as follows:

---

| | | |
|:---|:---|:---|
| **Lease Term and Discount Rate** | **June 30, 2025** | **December 26, 2024** |
| Weighted-average remaining lease terms: |  |  |
| &nbsp;&nbsp;Finance leases | 6 years | 6 years |
| &nbsp;&nbsp;Operating leases | 11 years | 11 years |
| Weighted-average discount rates: |  |  |
| &nbsp;&nbsp;Finance leases | 4.75% | 4.69% |
| &nbsp;&nbsp;Operating leases | 4.81% | 4.79% |

---

Deferred rent payments of approximately $506 for the Company's operating leases have been included in the total operating lease obligations as of June 30, 2025, of which approximately $56 is included in long-term operating lease obligations.

**4. Share-Based Compensation**

During the six months ended June 30, 2025, the Company granted restricted stock, restricted stock units (RSUs) and performance stock units (PSUs) to certain executives and associates. A summary of the Company's stock option, restricted stock, RSU and PSU activity follows, with PSUs reflected at the target achievement percentage until the completion of the performance period (shares in thousands).

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Stock Options** | **Stock Options** | **Restricted Stock & RSUs** | **Restricted Stock & RSUs** | **PSUs** | **PSUs** |
| | **Options** | **Weighted-Average Exercise Price** | **Shares / Units** | **Weighted-Average Fair Value** | **Units** | **Weighted-Average Fair Value** |
| December 26, 2024 | 2884 | $23.22 | 714 | $15.49 | 139 | $14.84 |
| &nbsp;&nbsp;Granted |  |  | 166 | 21.86 | 101 | 21.86 |
| &nbsp;&nbsp;Exercised <sup>(1)</sup> | (1) | 14.74 |  |  |  |  |
| &nbsp;&nbsp;Vested <sup>(2)</sup> |  |  | (74) | 16.89 |  |  |
| &nbsp;&nbsp;Forfeited | (25) | 21.96 | (2) | 16.25 | (2) | 16.25 |
| June 30, 2025 | 2858 | $23.24 | 804 | $16.68 | 238 | $17.80 |

---

(1)Exercise activity only applicable to stock options.

(2)Vesting activity not applicable to stock options.

Share-based compensation expense was $1,441 and $4,986, respectively, during the three and six months ended June 30, 2025, and $2,418 and $4,932, respectively, during the three and six months ended June 27, 2024. As of June 30, 2025, total unrecognized share-based compensation expense related to stock options was $1,028, which will be amortized to expense over the weighted-average remaining life of 1.5 years. As of June 30, 2025, total unrecognized share-based compensation expense related to non-vested restricted stock, RSUs and PSUs was $8,003, which will be amortized over the weighted-average remaining service period of 2.3 years.

Shareholders of The Marcus Corporation approved the adoption of the Marcus Corporation Omnibus Incentive Plan effective May 7, 2025 and authorized 2,000,000 shares available for issuance under the plan. At June 30, 2025, there were 1,848,086 shares available for grants of various equity awards under the plan.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

**5. Income Taxes**

The Company's effective income tax rate for the three and six months ended June 30, 2025 was 27.3% and 32.7%, respectively, and was (39.4)% and 4.9% for the three and six months ended June 27, 2024, respectively. The fiscal 2024 first half effective income tax rate was negatively impacted by a nondeductible debt conversion expense resulting from the Convertible Notes Repurchases and a $1,085 reduction in deferred tax assets resulting from the related termination of the Capped Call Transactions and excess compensation subject to deduction limitations.

On July 4, 2025, the One Big Beautiful Bill Act (the Act) was signed into law, introducing significant U.S. tax changes. Key provisions that may impact the Company are bonus depreciation and interest deductibility. The Company is currently evaluating the Act's potential impact on is Consolidated Financial Statements and will update its assessment as further guidance becomes available.

**6. Joint Venture Transactions**

In March 2024, the Company formed a joint venture with Hempel Real Estate ("Hempel") and Robinson Park ("RP") to acquire the Loews Minneapolis Hotel, a 251 guest room and suite full-service lifestyle hotel located in downtown Minneapolis, Minnesota. The acquired hotel was rebranded as The Lofton Hotel ("Lofton") under the Tapestry Collection by Hilton flag. The Company invested $5,620 for a 33.3% equity interest in the Lofton joint venture and entered into a management agreement for the hotel. Subsequent to its initial investment in the joint venture, the Company sold an 8.6% interest to a minority investor for $1,500, reducing its equity interest in the Lofton joint venture to 24.7%. The Company accounts for its investment in the Lofton joint venture on the equity method.

A wholly-owned subsidiary of the Lofton joint venture entity, as the borrower, financed the acquisition of and future improvements to the hotel with a mortgage loan. In connection with this mortgage loan, the Company provided an environmental indemnity and a several payment guaranty that provides that the lender can recover losses from the Company, a principal in Hempel, and a principal in RP for certain events of default of the borrower up to $6,200 for the Company. Under the terms of a cross-indemnity agreement among the guarantors, the other two guarantors have fully indemnified the Company under the guarantees for any losses in excess of its proportionate liability under the several payment guaranty and environmental indemnity.

**7. Business Segment Information**

The Company's primary operations are reported in the following two business segments: movie theatres and hotels and resorts. The Marcus Corporation's chief operating decision maker (CODM) is the Company's Chief Executive Officer. The measure of segment profit and loss the CODM uses to evaluate performance is operating income of each segment. The CODM uses this measure to evaluate trends and assess segment operating performance as compared to budget, historical periods, the industries each segment operates in and their competition in order to determine how to allocate resources to each segment. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

Following is a summary of business segment information for the three and six months ended June 30, 2025 and June 27, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** |
| | **Theatres** | **Hotels/Resorts** | **Total** | **Theatres** | **Hotels/Resorts** | **Total** |
| Total Revenues | $131650 | $74282 | $205932 | $101452 | $74497 | $175949 |
| Less: Costs and expenses | Less: Costs and expenses |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Theatre operations | 64172 |  | 64172 | 52118 |  | 52118 |
| &nbsp;&nbsp;&nbsp;Rooms |  | 11086 | 11086 |  | 11164 | 11164 |
| &nbsp;&nbsp;&nbsp;Theatre concessions | 23337 |  | 23337 | 18515 |  | 18515 |
| &nbsp;&nbsp;&nbsp;Food and beverage |  | 15656 | 15656 |  | 15080 | 15080 |
| &nbsp;&nbsp;&nbsp;Advertising and marketing | 1794 | 4804 | 6598 | 1533 | 4939 | 6472 |
| &nbsp;&nbsp;&nbsp;Administrative | 5852 | 10817 | 16669 | 5521 | 10715 | 16236 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 10455 | 6746 | 17201 | 11520 | 5048 | 16568 |
| &nbsp;&nbsp;&nbsp;Rent | 5783 | 467 | 6250 | 5872 | 489 | 6361 |
| &nbsp;&nbsp;&nbsp;Property taxes | 2847 | 1453 | 4300 | 2346 | 1325 | 3671 |
| &nbsp;&nbsp;&nbsp;Impairment charges |  |  |  | 472 |  | 472 |
| &nbsp;&nbsp;&nbsp;Reimbursed costs | 647 | 9724 | 10371 |  | 10733 | 10733 |
| &nbsp;&nbsp;&nbsp;Other segment items <sup>(1)</sup> | 1063 | 9335 | 10398 | 774 | 8887 | 9661 |
| Total costs and expenses | 115950 | 70088 | 186038 | 98671 | 68380 | 167051 |
| Operating income | $15700 | $4194 | $19894 | $2781 | $6117 | $8898 |
| &nbsp;&nbsp;&nbsp;Investment income |  |  | 409 |  |  | 173 |
| &nbsp;&nbsp;&nbsp;Interest expense |  |  | (2981) |  |  | (2564) |
| &nbsp;&nbsp;&nbsp;Other income (expense), net | &nbsp;&nbsp;&nbsp;Other income (expense), net |  | (443) |  |  | (390) |
| &nbsp;&nbsp;&nbsp;Debt conversion expense |  |  |  |  |  | (13908) |
| &nbsp;&nbsp;&nbsp;Equity earnings (losses) from unconsolidated joint ventures, net | &nbsp;&nbsp;&nbsp;Equity earnings (losses) from unconsolidated joint ventures, net |  | 75 |  |  | (50) |
| &nbsp;&nbsp;&nbsp;Corporate items <sup>(2)</sup> |  |  | (6887) |  |  | (6661) |
| Net earnings (loss) before income taxes | Net earnings (loss) before income taxes |  | $10067 |  |  | $(14502) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** | **Three Months Ended June 27, 2024** |
| | **Theatres** | **Hotels/<br>Resorts** | **Corporate**<br>**Items** <sup>(2)</sup> | **Total** | **Theatres** | **Hotels/<br>Resorts** | **Corporate**<br>**Items** <sup>(2)</sup> | **Total** |
| Additional Disclosures |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Share-based compensation | $187 | $274 | $980 | $1441 | $164 | $259 | $1995 | $2418 |
| &nbsp;&nbsp;&nbsp;Capital expenditures | 6065 | 10718 | 127 | 16910 | 3654 | 14657 | 1532 | 19843 |
| &nbsp;&nbsp;&nbsp;Assets | 627857 | 333075 | 55375 | 1016307 | 669103 | 309874 | 73121 | 1052098 |

---

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u>

**THE MARCUS CORPORATION**

**CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2025**

*(in thousands, except share and per share data)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** |
| | **Theatres** | **Hotels/Resorts** | **Total** | **Theatres** | **Hotels/Resorts** | **Total** |
| Total Revenues | $219007 | $135604 | $354611 | $182722 | $131694 | $314416 |
| Less: Costs and expenses | Less: Costs and expenses |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Theatre operations | 113842 |  | 113842 | 97103 |  | 97103 |
| &nbsp;&nbsp;&nbsp;Rooms |  | 20992 | 20992 |  | 20575 | 20575 |
| &nbsp;&nbsp;&nbsp;Theatre concessions | 40788 |  | 40788 | 33401 |  | 33401 |
| &nbsp;&nbsp;&nbsp;Food and beverage |  | 30285 | 30285 |  | 28943 | 28943 |
| &nbsp;&nbsp;&nbsp;Advertising and marketing | 2938 | 8868 | 11806 | 2614 | 9114 | 11728 |
| &nbsp;&nbsp;&nbsp;Administrative | 11777 | 22079 | 33856 | 11391 | 20706 | 32097 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 21161 | 13482 | 34643 | 22553 | 9912 | 32465 |
| &nbsp;&nbsp;&nbsp;Rent | 11435 | 928 | 12363 | 11651 | 956 | 12607 |
| &nbsp;&nbsp;&nbsp;Property taxes | 5738 | 2924 | 8662 | 4782 | 2782 | 7564 |
| &nbsp;&nbsp;&nbsp;Impairment charges |  |  |  | 472 |  | 472 |
| &nbsp;&nbsp;&nbsp;Reimbursed costs | 1481 | 18747 | 20228 |  | 19911 | 19911 |
| &nbsp;&nbsp;&nbsp;Other segment items <sup>(1)</sup> | 428 | 19149 | 19577 | 1713 | 17840 | 19553 |
| Total costs and expenses | 209588 | 137454 | 347042 | 185680 | 130739 | 316419 |
| Operating income (loss) | $9419 | $(1850) | $7569 | $(2958) | $955 | $(2003) |
| &nbsp;&nbsp;&nbsp;Investment income |  |  | 483 |  |  | 865 |
| &nbsp;&nbsp;&nbsp;Interest expense |  |  | (5803) |  |  | (5098) |
| &nbsp;&nbsp;&nbsp;Other income (expense), net | &nbsp;&nbsp;&nbsp;Other income (expense), net |  | (887) |  |  | (731) |
| &nbsp;&nbsp;&nbsp;Debt conversion expense |  |  |  |  |  | (13908) |
| &nbsp;&nbsp;&nbsp;Equity losses from unconsolidated joint ventures, net | &nbsp;&nbsp;&nbsp;Equity losses from unconsolidated joint ventures, net |  | (495) |  |  | (437) |
| &nbsp;&nbsp;&nbsp;Corporate items <sup>(2)</sup> |  |  | (14974) |  |  | (12425) |
| Net loss before income taxes | Net loss before income taxes |  | $(14107) |  |  | $(33737) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** | **Six Months Ended June 27, 2024** |
| | **Theatres** | **Hotels/<br>Resorts** | **Corporate**<br>**Items** <sup>(2)</sup> | **Total** | **Theatres** | **Hotels/<br>Resorts** | **Corporate**<br>**Items** <sup>(2)</sup> | **Total** |
| Additional Disclosures |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Share-based compensation | $683 | $596 | $3707 | $4986 | $604 | $541 | $3787 | $4932 |
| &nbsp;&nbsp;&nbsp;Capital expenditures | 10424 | 26621 | 2870 | 39915 | 6481 | 27002 | 1800 | 35283 |
| &nbsp;&nbsp;&nbsp;Assets | 627857 | 333075 | 55375 | 1016307 | 669103 | 309874 | 73121 | 1052098 |

---

<sup>(1)</sup> Other segment items includes losses or gains on disposition of property, equipment and other assets, preopening expenses, and other operating expenses.

<sup>(2)</sup> Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. Corporate assets primarily include cash and cash equivalents, furniture, fixtures and equipment, investments and land held for development.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

**THE MARCUS CORPORATION**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

**Special Note Regarding Forward-Looking Statements**

*Certain matters discussed in this Quarterly Report on Form 10-Q and the accompanying Management's Discussion and Analysis, are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we "believe," "anticipate," "expect" or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects future pandemics or epidemics may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (including disruptions in the production of films due to events such as tariffs or a strike by actors, writers or directors or future pandemics); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of tariffs that are implemented or merely threatened on our costs; (12) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (13) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (14) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States or other incidents of violence in public venues such as hotels and movie theatres; and (15) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.*

**RESULTS OF OPERATIONS**

**General**

For fiscal 2024 and prior periods, we reported our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December, dividing our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. Fiscal 2024 was a 52-week year with 364 operating days, beginning on December 29, 2023 and ending on December 26, 2024.

Beginning on December 27, 2024, our fiscal year changed from a 52- or 53-week fiscal year ending on the last Thursday in December of each year to a fiscal year ending on December 31 of each year. Accordingly, effective for our fiscal year ending December 31, 2025, our quarterly results will be for three month periods ending March 31, June 30, September 30 and December 31 of each year. Fiscal 2025 is a 370 operating day year beginning on December 27, 2024 and ending on December 31, 2025 (comprised of five operating days between December 27-31, 2024, plus 365 operating days in calendar year 2025).

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

The second quarter of fiscal 2025 consisted of the three month period beginning on April 1, 2025 and ended on June 30, 2025 and included the same number of operating days compared to the prior year quarter. The second quarter of fiscal 2024 consisted of the three month period beginning March 29, 2024 and ended on June 27, 2024. The first half of fiscal 2025 consisted of the six month period beginning on December 27, 2024 and ended on June 30, 2025 and included four additional operating days compared to the prior year period. The first half of fiscal 2024 consisted of the six month period beginning on December 29, 2023 and ended on June 27, 2024.

Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.

**Overall Results**

The following table sets forth revenues, operating income (loss), other income (expense), net earnings (loss) and net earnings (loss) per diluted common share for the second quarter and first half of fiscal 2025 and fiscal 2024 (in millions, except for per share and variance percentage data):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Revenues | $206.0 | $176.0 | $30.0 | 17.0% | $354.8 | $314.6 | $40.2 | 12.8% |
| Operating income (loss) | 13.0 | 2.2 | 10.8 | 481.4% | (7.4) | (14.4) | 7.0 | 48.7% |
| Other income (expense) | (2.9) | (16.7) | 13.8 | 82.4% | (6.7) | (19.3) | 12.6 | 65.3% |
| Net earnings (loss) | $7.3 | $(20.2) | $27.5 | 136.2% | $(9.5) | $(32.1) | $22.6 | 70.4% |
| Net earnings (loss) per common share - diluted | $0.23 | $(0.64) | $0.87 | 135.9% | $(0.31) | $(1.03) | $0.72 | 69.9% |

---

Revenues increased and operating income (loss), net earnings (loss), and net earnings (loss) per diluted common share improved during the second quarter and first half of fiscal 2025 compared to the second quarter and first half of fiscal 2024 primarily due to increased revenues from our theatre division. Hotels and resorts division revenues during the second quarter of fiscal 2025 remained consistent with the second quarter of fiscal 2024, and increased during the first half of fiscal 2025 compared to the first half of fiscal 2024. Revenues in the first half of fiscal 2025 were favorably impacted by four additional operating days compared to the first half of fiscal 2024, which included two additional days during the week between the Christmas and New Year's holidays and two additional days at the end of March 2025. The four additional operating days (which occurred during the fiscal 2025 first quarter) favorably impacted revenues by approximately $9.2 million.

Operating income during the second quarter of fiscal 2025 increased $10.8 million primarily due to increased revenues in our Theatre division, and was unfavorably impacted by increased corporate expenses and an increase in depreciation expense of $0.9 million compared to the second quarter of fiscal 2024. Operating loss during the first half of fiscal 2025 improved $7.0 million compared to the first half of fiscal 2024 due to increased revenues in both divisions, and was negatively impacted by increased corporate expenses and increased depreciation expense of $2.7 million over the prior year period.

Corporate expenses during the second quarter of fiscal 2025 increased $0.2 million compared to the second quarter of fiscal 2024 due to increases in depreciation expense, long-term incentive compensation expenses, professional fees, and personnel and benefits cost inflation, partially offset by a favorable $1.0 million decrease in non-cash stock compensation expense. Corporate expenses during the first half of fiscal 2025 increased $2.5 million compared to the first half of fiscal 2024 due to increases in depreciation, long-term incentive compensation expenses, professional fees related to tax, audit and legal services, and personnel and benefits cost inflation.

In addition, operating income during the second quarter of fiscal 2025 was negatively impacted by a $0.2 million loss on disposition of property, equipment and other assets compared to an immaterial gain on disposition of property, equipment and other assets during the second quarter of fiscal 2024. Operating loss during the first half of fiscal 2025 was favorably impacted by a $1.2 million gain on disposition of property, equipment and other assets due largely to the sale of surplus land, compared to an immaterial gain during the first half of fiscal 2024.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

Other income (expense) and net earnings (loss) during the second quarter and first half of fiscal 2025 were impacted by an increase in interest expense, fluctuations in investment income, and a decrease in debt conversion expense compared with the second quarter and first half of fiscal 2024.

Our interest expense totaled $3.0 million and $5.8 million for the second quarter and first half of fiscal 2025, respectively, compared to $2.6 million and $5.1 million for the second quarter and first half of fiscal 2024, respectively. The increase in interest expense during the second quarter and first half of fiscal 2025 was primarily due to increased borrowings and higher interest rates, partially offset by a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.

We recognized investment income of $0.4 million and $0.5 million during the second quarter and first half of fiscal 2025, respectively, compared to $0.2 million and $0.9 million during the second quarter and first half of fiscal 2024, respectively. Variations in investment income were due to changes in the value of marketable securities.

Other income (expense) and net earnings (loss) during the second quarter and first half of fiscal 2024 were negatively impacted by debt conversion expense of $13.9 million in connection with the $86.4 million aggregate principal amount of Convertible Notes Repurchases. See *"2024 Convertible Senior Notes Repurchases"* in the "Liquidity and Capital Resources" section of this MD&A for further discussion.

Net earnings (loss) and net earnings (loss) per diluted common share improved during the second quarter and first half of fiscal 2025 compared to the second quarter and first half of fiscal 2024 resulting from an improvement in operating income (loss), and a decrease in other expense, which was negatively impacted by debt conversion expense of $13.9 million during the prior year comparable periods.

We reported income tax expense of $2.7 million for the second quarter of fiscal 2025 compared to expense of $5.7 million during the second quarter of fiscal 2024. We reported income tax benefit of $4.6 million for the first half of fiscal 2025 compared to benefit of $1.7 million for the first half of fiscal 2024. Our fiscal 2025 first half effective income tax rate was 32.7% and was negatively impacted by excess compensation subject to deduction limitations. Our fiscal 2024 first half effective income tax rate was 4.9%, and was negatively impacted by nondeductible debt conversion expense resulting from the Convertible Notes Repurchases and a $1.1 million reduction in deferred tax assets resulting from the related termination of the Capped Call Transactions (combined negative impact of 7.5 percentage points) and excess compensation subject to deduction limitations. We anticipate that our effective income tax rate for fiscal 2025 may be in the 28% to 32% range, excluding any potential changes in federal or state income tax rates, valuation allowance adjustments or other one-time tax benefits. Our actual fiscal 2025 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.

**Theatres**

The following table sets forth revenues, operating income (loss) and operating margin for our theatre division for the second quarter and first half of fiscal 2025 and fiscal 2024 (in millions, except for variance percentage and operating margin):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Revenues | $131.7 | $101.5 | $30.2 | 29.8% | $219.0 | $182.7 | $36.3 | 19.9% |
| Operating income (loss) | 15.7 | 2.8 | 12.9 | 464.5% | 9.4 | (3.0) | 12.4 | 418.4% |
| Operating margin (% of revenues) | 11.9% | 2.7% |  |  | 4.3% | (1.6)% |  |  |

---

Our theatre division revenues and operating income (loss) improved with stronger performances from films resulting in increased attendance during the second quarter and first half of fiscal 2025, compared to the second quarter and first half of fiscal 2024. The quality and quantity of films released in second quarter and first half of fiscal 2025 improved compared to the second quarter and first half of fiscal 2024, which was negatively impacted by the content and supply chain disruption following the WGA and SAG-AFTRA labor strikes in 2023, resulting in a weaker slate of films in the first half of fiscal 2024. While the second quarters of fiscal 2025 and 2024 included a comparable number of operating days, the first half of

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

fiscal 2025 benefited from four additional operating days compared to the first half of fiscal 2024 (which occurred during the fiscal 2025 first quarter).

The following table provides a further breakdown of the components of revenues for the theatre division for the second quarter and first half of fiscal 2025 and fiscal 2024 (in millions, except for variance percentage):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Admission revenues | $62.3 | $48.6 | $13.8 | 28.3% | $103.3 | $89.2 | $14.1 | 15.8% |
| Concession revenues | 57.6 | 44.4 | 13.2 | 29.7% | 95.6 | 79.1 | 16.5 | 20.9% |
| Other revenues | 11.0 | 8.5 | 2.6 | 30.6% | 18.6 | 14.4 | 4.2 | 29.1% |
| &nbsp;&nbsp;Total revenues before cost <br>&nbsp;&nbsp;&nbsp;&nbsp;reimbursements | 131.0 | 101.5 | 29.6 | 29.1% | 217.5 | 182.7 | 34.8 | 19.0% |
| Cost reimbursements | 0.6 |  | 0.6 | n/m | 1.5 |  | 1.5 | n/m |
| Total revenues | 131.7 | 101.5 | 30.2 | 29.8% | 219.0 | 182.7 | 36.3 | 19.9% |

---

According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal 2025 second quarter and first half results, U.S. box office receipts increased 36.5% and 21.4% during our fiscal 2025 second quarter and first half, respectively, compared to our fiscal 2024 second quarter and first half, indicating that our increase in admission revenues for comparable theatres (excluding theatres closed during the past year) of 29.3% and 16.6% during the second quarter and first half of fiscal 2025 underperformed the industry by 7.2 and 4.8 percentage points, respectively. We believe our under performance in the second quarter and first half of fiscal 2025 was largely attributable to strategic pricing decisions made during the release of blockbuster films (we did not raise prices on most blockbuster films, unlike many national exhibitors) and our value promotions, resulting in lower average ticket price growth compared to other exhibitors. We believe our pricing strategies promote the affordability of moviegoing for customers at a variety of price points and will benefit our long-term theatre attendance. We believe our underperformance was also the result of an unfavorable film mix, with certain titles that were more appealing to audiences in other parts of the U.S. than in our Midwestern markets.

Additional data received and compiled by us from Comscore indicates our admission revenues at comparable theatres during the second quarter and first half of fiscal 2025 represented approximately 2.8% and 2.9%, respectively, of the total admission revenues in the U.S. (commonly referred to as market share in our industry), compared to 3.0% during the both the second quarter and first half of fiscal 2024. Our goal is to outperform the industry, but our ability to do so in any given quarter will likely be partially dependent upon film mix, pricing strategies, weather and the competitive landscape in our markets.

Total theatre attendance for our comparable theatres increased 26.7% during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024, which was attributable to a stronger film slate, higher box office performance from the top films, and an increase in the number of films released during second quarter of fiscal 2025 compared to the second quarter of fiscal 2024. During the second quarter of fiscal 2025, there were 32 wide-release films (films shown in over approximately 1,500 theatres in the U.S.) compared to 28 wide-release films during the second quarter of fiscal 2024. On a calendar quarter basis (April 1 through June 30), total theatre attendance for our comparable theatres increased 26.2% during the second quarter of 2025 compared to the second quarter of 2024.

Total theatre attendance for our comparable theatres increased 17.8% during the first half of fiscal 2025 compared to the first half of fiscal 2024, resulting primarily from the stronger film slate in second quarter of fiscal 2025. In addition, our total theatre attendance during the first half of fiscal 2025 benefited from an increased number of operating days during the first quarter of fiscal 2025 compared to the first quarter of fiscal 2024 due to the transition of our fiscal quarter as described above. On a calendar quarter basis (January 1 through June 30), total theatre attendance for our comparable theatres increased 10.8% during first half of fiscal 2025 compared to the first half of fiscal 2024.

Our highest grossing films during the fiscal 2025 second quarter included *A Minecraft Movie, Lilo & Stitch, Sinners, How to Train Your Dragon,* and *Thunderbolts\**. Our top five films during our fiscal 2025 second quarter accounted for 59% of our total box office results, compared to 56% for the top five films during the second quarter of fiscal 2024, both expressed as a percentage of the total admission revenues for the relevant period. An increased concentration of blockbuster films

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

during a given quarter often has the effect of increasing our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. As a result of a more concentrated film slate, our overall film cost as a percentage of admission revenues increased during the second quarter of fiscal 2025 compared to the same period in the prior fiscal year.

Our average ticket price increased 2.0% during the second quarter of fiscal 2025, compared to the second quarter of fiscal 2024. Our average ticket price during the second quarter of fiscal 2025 was favorably impacted by an increased percentage of ticket sales coming from premium large format (PLF) screens and a decrease in the percentage of attendance coming from Value Tuesday, partially offset by an unfavorable ticket mix with an increase in child attendance resulting from an increased number of family films during the quarter. Additionally, the average ticket price was negatively impacted by promotional pricing, including $7 Everyday Matinee for seniors and children that was introduced during the second quarter fiscal 2024. The overall change in average ticket price favorably impacted our admission revenues of our comparable theatres by $1.2 million during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024.

Our average ticket price decreased 1.1% during the first half of fiscal 2025, compared to the first half of fiscal 2024, resulting from the unfavorable impact of the $7 Everyday Matinee promotional offering for seniors and children and an unfavorable ticket mix with an increase in child attendance resulting from an increased number of family films, partially offset by the favorable impact of an increased percentage of ticket sales coming from premium large format (PLF) screens. The overall change in average ticket price unfavorably impacted our admission revenues of our comparable theatres by $1.1 million during the first half of fiscal 2025 compared to the first half of fiscal 2024.

Our average concession revenues per person increased by 3.1% and 3.4% during the second quarter and first half of fiscal 2025, respectively, compared to the second quarter and first half of fiscal 2024, resulting from an increase in movie merchandise sales and menu price increases. The overall increase in average concession revenues per person favorably impacted our concession revenues of our comparable theatres by $1.9 million and $3.2 million during the second quarter and first half of fiscal 2025, respectively, compared to the second quarter and first half of fiscal 2024.

Other revenues during the second quarter and first half of fiscal 2025 increased by $2.6 million and $4.2 million, respectively, compared to the second quarter and first half of fiscal 2024, due to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising revenue. Late during the first quarter of fiscal 2024, we made changes to the criteria for waiving internet surcharge ticket fees for our MMR members, resulting in an increase in ticketing fees per person during most of the first quarter of fiscal 2025.

We ended the second quarter of fiscal 2025 with a total of 971 company-owned screens in 77 theatres and 14 managed screens at one theatre, compared to 981 company-owned screens in 78 theatres at the end of the second quarter of fiscal 2024. We made decisions to close underperforming theatres during fiscal 2024 and fiscal 2025, including one leased theatre in the second quarter of fiscal 2024, and one leased Movie Tavern theatre in the first quarter of fiscal 2025. During the third quarter of fiscal 2024, we added one theatre that we manage for the owner of a lifestyle shopping center.

**Hotels and Resorts**

The following table sets forth revenues, operating income (loss) and operating margin for our hotels and resorts division for the second quarter and first half of fiscal 2025 and fiscal 2024 (in millions, except for variance percentage and operating margin):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Revenues | $74.3 | $74.5 | $(0.2) | (0.3)% | $135.6 | $131.7 | $3.9 | 3.0% |
| Operating income (loss) | 4.2 | 6.1 | (1.9) | (31.4)% | (1.9) | 1.0 | (2.8) | (293.7)% |
| Operating margin (% of revenues) | 5.6% | 8.2% |  |  | (1.4)% | 0.7% |  |  |

---

Hotels and resorts division revenues decreased 0.3% during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024. Division operating income during the second quarter of fiscal 2025 decreased $1.9 million compared to the second quarter of fiscal 2024, and was negatively impacted by an increase in depreciation expense of $1.7 million due to hotel renovations completed during fiscal 2024 as well as higher repair costs following a water damage event at one hotel. During the first half of fiscal 2025, hotels and resorts division revenues increased 3.0% and benefited from four

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

additional operating days compared to the first half of fiscal 2024 (which occurred during the first quarter of fiscal 2025). Operating income (loss) declined $2.8 million during the first half of fiscal 2025, compared to the first half of fiscal 2024, due to a $3.6 million increase in depreciation expense partially offset by the favorable impact of the increase in revenues.

The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the second quarter and first half of fiscal 2025 and fiscal 2024 (in millions, except for variance percentage):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Room revenues | $29.6 | $30.5 | $(0.9) | (2.8)% | $48.9 | $48.7 | $0.2 | 0.4% |
| Food/beverage revenues | 21.3 | 19.3 | 2.0 | 10.5% | 39.1 | 35.4 | 3.7 | 10.4% |
| Other revenues | 13.6 | 14.0 | (0.4) | (2.6)% | 28.8 | 27.6 | 1.2 | 4.3% |
| &nbsp;&nbsp;Total revenues before cost reimbursements | 64.6 | 63.8 | 0.8 | 1.2% | 116.9 | 111.8 | 5.1 | 4.5% |
| Cost reimbursements | 9.7 | 10.7 | (1.0) | (9.4)% | 18.7 | 19.9 | (1.2) | (5.8)% |
| &nbsp;&nbsp;Total revenues | $74.3 | $74.5 | $(0.2) | (0.3)% | $135.6 | $131.7 | $3.9 | 3.0% |

---

Division total revenues before cost reimbursements increased 1.2% during the second quarter of fiscal 2025, compared to the second quarter of fiscal 2024, due largely to increased group demand contributing to growth in food and beverage revenues, partially offset by a decrease in rooms revenue which was negatively impacted by rooms out of service due to the renovation of the Hilton Milwaukee, as well as lower transient demand at some properties. Division total revenues before cost reimbursements increased 4.5% during the first half of fiscal 2025, compared to the first half of fiscal 2024, resulting primarily from an additional four operating days, growth in food and beverage revenues, as well as an increase in other revenues driven primarily by a group buyout of one condo hotel property during a portion of the first quarter, partially offset by the negative impact of the Hilton Milwaukee renovation.

The following table sets forth certain operating statistics for the second quarter and first half of fiscal 2025 and fiscal 2024, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for comparable company-owned properties:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Occupancy pct. | 67.3% | 72.7% | (5.4) pts | (7.4)% | 58.6% | 63.2% | (4.6) pts | (7.3)% |
| ADR | $196.35 | $187.03 | $9.32 | 5.0% | $181.34 | $171.36 | $9.98 | 5.8% |
| RevPAR | $132.07 | $136.03 | $(3.96) | (2.9)% | $106.22 | $108.30 | $(2.08) | (1.9)% |

---

*Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort.* 

RevPAR increased at four of our seven comparable company-owned properties during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024, driven primarily by increased average daily rates. Group business grew as a percentage of our mix of business, representing approximately 47.1% of our total rooms revenue in the second quarter of fiscal 2025, compared to approximately 44.6% during the second quarter of fiscal 2024. Non-group pricing increased in some of our major markets during the second quarter of fiscal 2025, primarily due to increased rate compression at our other Milwaukee market hotels as a result of the renovation at the Hilton Milwaukee.

According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal 2025 second quarter and first half results, comparable "upper upscale" hotels—hotels identified as our industry— throughout the United States experienced flat RevPAR during our fiscal 2025 second quarter compared to our fiscal 2024 second quarter, leading us to believe we underperformed the industry during the fiscal 2025 second quarter by approximately 2.9 percentage points. During the first half of fiscal 2025, comparable "upper upscale" hotels experienced RevPAR growth of 1.3%, compared to the first half of fiscal 2024, leading us to believe we underperformed the industry during the first half of fiscal

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

2025 by approximately 3.2 percentage points. We believe our underperformance during the second quarter and first half of fiscal 2025 resulted primarily from the unfavorable impact of the Hilton Milwaukee renovation and group displacement as a result of the reduced capacity. We estimate that the Hilton Milwaukee renovation negatively impacted our RevPAR growth by approximately 3.7 and 3.6 percentage points during the fiscal 2025 second quarter and first half, respectively.

Data received from Smith Travel Research for our various "competitive sets"—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced an increase in RevPAR of 2.9% during our fiscal 2025 second quarter, again compared to our fiscal 2024 second quarter. Therefore, we underperformed our competitive sets during the second quarter of fiscal 2025 by approximately 5.8 percentage points. During the first half of fiscal 2025, hotels in our competitive sets experienced RevPAR growth of 3.6%, indicating that we underperformed our competitive set hotels by 5.5 percentage points. We believe the underperformance to our competitive sets during the second quarter and first half of fiscal 2025 resulted primarily from group displacement at the Hilton Milwaukee while under renovation which we believe unfavorably impacted our RevPAR growth while favorably impacting competitive hotels RevPAR growth. After adjusting for the estimated impact of the Hilton Milwaukee renovation, we believe our hotels underperformed their competitive sets during the second quarter and first half of fiscal 2025 by approximately 1.3 and 1.0 percentage points, respectively. We believe this underperformance was driven largely by new hotel room supply within one of our markets.

We generally expect our revenue trends to track or exceed the overall industry trends for our segment of the industry, particularly in our respective markets. Hotel revenues have historically tracked very closely with traditional macroeconomic statistics, such as the Gross Domestic Product. The U.S. economic outlook has moved into a period of heightened uncertainty. In the near term, we expect leisure travel demand to soften, and we expect our group business to remain stable. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder in our primarily Midwestern markets.

As of the date of this report, our group room revenue bookings for the remainder of fiscal 2025 - commonly referred to in the hotels and resorts industry as "group pace" - is running in-line with where we were at the same time last year, and is running approximately 11% ahead of where we were at the same time last year excluding bookings related to the July 2024 Republican National Convention. Group room revenue bookings for fiscal 2026 is running nearly 20% ahead of where we were at the same time in fiscal 2024 for fiscal 2025. Banquet and catering revenue pace for fiscal 2025 is running approximately 15% ahead of where we were at the same time last year, and fiscal 2026 is running approximately 20% ahead of where we were at the same time in fiscal 2024 for fiscal 2025.

**Adjusted EBITDA**

Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.

Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management's discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.

We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, impairment charges, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes, depreciation and amortization and non-cash share-based compensation expense, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.

The following table sets forth Adjusted EBITDA by reportable operating segment for the second quarter and first halfof fiscal 2025 and fiscal 2024 (in millions, except for variance percentage):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** | **First Half** | **First Half** |
| | | | **Variance** | **Variance** | | | **Variance** | **Variance** |
| |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |<br>**F2025** |<br>**F2024** | **Amt.** | **Pct.** |
| Theatres | $26.5 | $15.1 | $11.5 | 76.2% | $30.2 | $21.2 | $9.0 | 42.5% |
| Hotels and resorts | 11.2 | 11.4 | (0.2) | (1.8)% | 12.2 | 11.4 | 0.8 | 7.2% |
| Corporate items | (5.5) | (4.5) | (1.0) | (21.4)% | (10.5) | (8.4) | (2.1) | (24.8)% |
| &nbsp;&nbsp;Total Adjusted EBITDA | $32.3 | $22.0 | $10.3 | 46.9% | $32.0 | $24.3 | $7.8 | 32.0% |

---

Our theatre division Adjusted EBITDA increased during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024 due to increased revenues and increased operating leverage with the higher volumes, partially offset by increases in film costs, advertising costs, facility maintenance and other expenses. Our hotels and resorts division Adjusted EBITDA decreased during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024 and was negatively impacted by changes in revenue mix, with a decrease in higher margin rooms revenue offset by an increase in lower margin food and beverage revenue, as well as higher repair costs following a water damage event at one hotel and higher associate benefits costs. Adjusted EBITDA attributable to corporate items decreased during the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024 due primarily to increased long-term incentive compensation expenses as well as personnel and benefits cost inflation, partially offset by a decrease in professional fees related to legal services.

During the first half of fiscal 2025, theatre division Adjusted EBITDA increased compared to the first half of fiscal 2024, due to higher revenue resulting from increased attendance and four additional operating days in the fiscal 2025 first quarter, as described above, partially offset by increased film costs and labor expenses. Our hotels and resorts Adjusted EBITDA increased during the first half of fiscal 2025 compared to the first half of fiscal 2024 due to higher revenue resulting from additional operating days and an increase in group business, partially offset by increased associate benefits costs and repair costs. Adjusted EBITDA attributable to corporate items decreased during the first half of fiscal 2025 compared to the first half of fiscal 2024 due primarily to increased long-term incentive compensation expenses, professional fees related to tax, audit, and legal services, and personnel and benefits cost inflation.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

The following table sets forth our reconciliation of Adjusted EBITDA (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **First Half** | **First Half** |
| | **F2025** | **F2024** | **F2025** | **F2024** |
| Net earnings (loss) | $7.3 | $(20.2) | $(9.5) | $(32.1) |
| Add (deduct): |  |  |  |  |
| &nbsp;&nbsp;Investment (income) loss | (0.4) | (0.2) | (0.5) | (0.9) |
| &nbsp;&nbsp;Interest expense | 3.0 | 2.6 | 5.8 | 5.1 |
| &nbsp;&nbsp;Other (income) expense | 0.4 | 0.4 | 0.9 | 0.7 |
| &nbsp;&nbsp;Loss (gain) on disposition of property, equipment and other assets | 0.2 |  | (1.2) |  |
| &nbsp;&nbsp;Equity (earnings) losses from unconsolidated joint ventures | (0.1) | 0.1 | 0.5 | 0.4 |
| &nbsp;&nbsp;Income tax expense (benefit) | 2.7 | 5.7 | (4.6) | (1.7) |
| &nbsp;&nbsp;Depreciation and amortization | 17.6 | 16.7 | 35.4 | 32.7 |
| &nbsp;&nbsp;Share-based compensation expenses <sup>(1)</sup> | 1.4 | 2.4 | 5.0 | 4.9 |
| &nbsp;&nbsp;Impairment charges <sup>(2)</sup> |  | 0.5 |  | 0.5 |
| &nbsp;&nbsp;Theatre exit costs <sup>(3)</sup> |  | 0.1 | 0.1 | 0.1 |
| &nbsp;&nbsp;Insured losses <sup>(4)</sup> |  |  |  | 0.4 |
| &nbsp;&nbsp;Debt conversion expense <sup>(5)</sup> |  | 13.9 |  | 13.9 |
| Total Adjusted EBITDA | $32.3 | $22.0 | $32.0 | $24.3 |

---

The following tables set forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter, F2025** | **Second Quarter, F2025** | **Second Quarter, F2025** | **Second Quarter, F2025** | **First Half, F2025** | **First Half, F2025** | **First Half, F2025** | **First Half, F2025** |
| | **Theatres** | **Hotels & Resorts** | **Corp. Items** | **Total** | **Theatres** | **Hotels & Resorts** | **Corp. Items** | **Total** |
| Operating income (loss) | $15.7 | $4.2 | $(6.9) | $13 | $9.4 | $(1.9) | $(15.0) | $(7.4) |
| Depreciation and amortization | 10.5 | 6.7 | 0.4 | 17.6 | 21.2 | 13.5 | 0.8 | 35.4 |
| Loss (gain) on disposition of property, equipment and other assets | 0.2 |  |  | 0.2 | (1.2) |  |  | (1.2) |
| Share-based compensation <sup>(1)</sup> | 0.2 | 0.3 | 1.0 | 1.4 | 0.7 | 0.6 | 3.7 | 5.0 |
| Theatre exit costs <sup>(3)</sup> |  |  |  |  | 0.1 |  |  | 0.1 |
| &nbsp;&nbsp;Total Adjusted EBITDA | $26.5 | $11.2 | $(5.5) | $32.3 | $30.2 | $12.2 | $(10.5) | $32 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter, F2024** | **Second Quarter, F2024** | **Second Quarter, F2024** | **Second Quarter, F2024** | **First Half, F2024** | **First Half, F2024** | **First Half, F2024** | **First Half, F2024** |
| | **Theatres** | **Hotels & Resorts** | **Corp. Items** | **Total** | **Theatres** | **Hotels & Resorts** | **Corp. Items** | **Total** |
| Operating income (loss) | $2.8 | $6.1 | $(6.7) | $2.2 | $(3.0) | $1.0 | $(12.4) | $(14.4) |
| Depreciation and amortization | 11.5 | 5.0 | 0.1 | 16.7 | 22.6 | 9.9 | 0.2 | 32.7 |
| Share-based compensation <sup>(1)</sup> | 0.2 | 0.3 | 2.0 | 2.4 | 0.6 | 0.5 | 3.8 | 4.9 |
| Impairment charges <sup>(2)</sup> | 0.5 |  |  | 0.5 | 0.5 |  |  | 0.5 |
| Theatre exit costs <sup>(3)</sup> | 0.1 |  |  | 0.1 | 0.1 |  |  | 0.1 |
| Insured losses <sup>(4)</sup> |  |  |  |  | 0.4 |  |  | 0.4 |
| &nbsp;&nbsp;Total Adjusted EBITDA | $15.1 | $11.4 | $(4.5) | $22.0 | $21.2 | $11.4 | $(8.4) | $24.3 |

---

(1)Non-cash expense related to share-based compensation programs.

(2)Non-cash impairment charges related to one permanently closed theatre location in the second quarter of fiscal 2024.

(3)Reflects non-recurring costs related to the closure and exit of one theatre location in the first quarter of fiscal 2025 and one theatre location in the second quarter of fiscal 2024.

(4)Repair costs related to insured property damage at one theatre location that are non-operating in nature.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

(5)Debt conversion expense resulting from repurchases of $86.4 million aggregate principal amount of Convertible Notes. See *Convertible Senior Notes Repurchases* in the "Liquidity and Capital Resources" section of this MD&A for further discussion.

**LIQUIDITY AND CAPITAL RESOURCES**

**Liquidity**

Our movie theatre and hotels and resorts businesses each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment's revenue is derived predominantly from consumer cash purchases. We believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses. However, our cash position may fluctuate from time-to-time based on seasonality of our businesses, the timing of interest payments on our debt as well as timing of payment of other operating expenses that are paid on an infrequent basis.

Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our 90-year history and our financial position remains strong. As of June 30, 2025, we had a cash balance of approximately $14.9 million, $199.2 million of availability under our $225 million revolving credit facility, our debt-to-capitalization ratio was 0.29, and our net leverage ratio was 1.61x net debt to Adjusted EBITDA. With our strong liquidity position combined with cash generated from operations, we believe we have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial statements, as well as fund our longer-term capital requirements.

The following table sets forth our reconciliations of Net Debt and Net Leverage (Net Debt to Adjusted EBITDA) (in millions, except leverage ratio):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 26, 2024** |
| Long-term debt (GAAP measure) <sup>(1)</sup> | $179.9 | $159.1 |
| Finance lease obligations (GAAP measure) <sup>(2)</sup> | 12.4 | 13.0 |
| Less: Cash and cash equivalents | (14.9) | (40.8) |
| &nbsp;&nbsp;Net Debt | $177.3 | $131.3 |
| Net Debt | $177.3 | $131.3 |
| LTM Adjusted EBITDA <sup>(3)</sup> | 110.2 | 102.4 |
| &nbsp;&nbsp;Net Leverage (Net Debt to Adjusted EBITDA) | 1.61x | 1.28x |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Represents total long-term debt, including the current portion of long-term debt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Represents total finance lease obligations, including the current portion of finance lease obligations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)LTM Adjusted EBITDA is Adjusted EBITDA as reconciled and defined above for the last four fiscal quarters.

We believe Net Leverage is a useful measure, as it provides management and investors an indication of our indebtedness less unrestricted cash relative to our earnings performance.

**Financial Condition**

Net cash used in operating activities totaled $3.7 million during the first half of fiscal 2025, compared to net cash provided by operating activities of $20.9 million during the first half of fiscal 2024. The $24.6 million increase in net cash used in operating activities was primarily due to a $19.4 million unfavorable impact from the seasonal timing of payments of accounts payable, a $7.5 million increase in prepaid and other assets, a $4.8 million unfavorable impact from timing of accrued compensation payments and a $13.9 million non-cash debt conversion expense in the prior year that did not recur, partially offset by a $22.6 million increase in net earnings and increases in non-cash depreciation and amortization.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

Net cash used in investing activities during the first half of fiscal 2025 totaled $31.5 million, compared to net cash used in investing activities of $40.6 million during the first half of fiscal 2024. The decrease in net cash used in investing activities of $9.1 million was the result of a decrease in net contributions to hotel joint ventures in the prior year period that did not recur and $8.2 million in proceeds from the sale of trading securities during the first half of fiscal 2025 compared to $1.1 million in purchases of trading securities in the first half of fiscal 2024, partially offset by an increase of $4.6 million in capital expenditures. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled $39.9 million during the first half of fiscal 2025 compared to $35.3 million during the first half of fiscal 2024. In fiscal 2024, we contributed $5.6 million for the purchase of joint venture interests in The Lofton Hotel, partially offset by a $1.5 million sale of joint venture interests in The Lofton Hotel to other minority investors.

Fiscal 2025 first half cash capital expenditures included approximately $10.4 million incurred in our theatre division, primarily related to normal maintenance capital projects. We incurred capital expenditures in our hotels and resorts division during the first half of fiscal 2025 of approximately $26.6 million, including costs related to guest room renovations at Hilton Milwaukee and normal maintenance capital projects. We incurred corporate capital expenditures during the first half of fiscal 2025 of approximately $2.9 million, which includes $1.2 million for the purchase of land acquired in a 1031 tax-deferred exchange for future development, and the final costs related to office construction for the relocation of our corporate and divisional headquarters that occurred during fiscal 2024.

Net cash provided by financing activities during the first half of fiscal 2025 totaled $7.4 million compared to net cash used in financing activities of $2.3 million during the first half of fiscal 2024. During the first half of fiscal 2025, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added $105.0 million of new short-term revolving credit facility borrowings, and we made $84.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2025 (net $21.0 million increase in borrowings on our credit facility). We ended the second quarter of fiscal 2025 with $21.0 million of outstanding borrowings under our revolving credit facility. During the first half of fiscal 2024, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added $81.0 million of new short-term revolving credit facility borrowings, and we made $36.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2024 (net $45.0 million increase in borrowings on our credit facility).

Principal payments on long-term debt were approximately $0.4 million during the first half of fiscal 2025 compared to payments of $0.7 million during the first half of fiscal 2024.

During the first half of fiscal 2024 we paid $46.5 million in cash for the Convertible Notes Repurchases (as defined below) and related transaction costs. We received $5.8 million in cash from the proportionate unwind of the Capped Call Transactions in connection with the Convertible Notes Repurchases during the first half of fiscal 2024. See *"2024 Convertible Senior Notes Repurchases"* for further discussion below.

Our debt-to-capitalization ratio (excluding our finance and operating lease obligations) was 0.29 at June 30, 2025, compared to 0.26 at December 26, 2024.

During the first half of fiscal 2025, we repurchased 0.4 million shares of our common stock for $7.1 million in the open market, compared to no share repurchases of our common stock in the open market during the first half of fiscal 2024. As of June 30, 2025, approximately 1.3 million shares remained available for repurchase under prior Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.

Dividends paid during the first half of fiscal 2025 were $4.3 million. Dividends paid during the first half of fiscal 2024 were $4.4 million. We have the ability to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.

*2024 Convertible Senior Notes Repurchases*

During the second quarter of fiscal 2024, we entered into separate, privately negotiated purchase agreements (the "Purchase Agreements") with certain holders of its Convertible Notes. Under the terms of the Purchase Agreements, the holders

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

agreed to exchange $86.4 million in aggregate principal amount of Convertible Notes for cash consideration of $101.1 million (or $87.9 million net of the cash we received in connection with the unwind of a portion of the Capped Call Transactions as discussed below) effected over two separate repurchase tranches (the "Convertible Notes Repurchases"). On May 8, 2024, we entered into the first repurchase transaction to retire $40.0 million of aggregate principal amount of Convertible Notes for $45.9 million in cash consideration plus accrued interest, with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, we entered into the second repurchase transaction to retire $46.4 million of aggregate principal amount of Convertible Notes for $55.2 million in cash consideration plus accrued interest, with settlement occurring during the fiscal third quarter on July 16, 2024.

In connection with the Convertible Notes Repurchases, we entered into unwind agreements with the Capped Call Counterparties to terminate a portion of the Capped Call Transactions equal to the notional amounts of the Convertible Notes Repurchases, and to receive aggregate cash of $13.2 million effected over two separate unwind tranches. On May 8, 2024, we entered into the first tranche of unwind agreements and received $5.8 million in cash consideration with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, we entered into the second tranche of unwind agreements and received $7.5 million in cash consideration at settlement occurring during the fiscal third quarter on July 16, 2024.

During the second quarter and first half of fiscal 2024, we incurred debt conversion expense of $13.9 million in connection with the Convertible Notes Repurchases. The unwind of the Capped Call Transactions resulted in a $12.9 million increase in capital in excess of par within shareholders' equity during the second quarter and first half of fiscal 2024.

**Critical Accounting Policies and Estimates**

We have included a summary of our Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 26, 2024. There have been no material changes to the summary provided in that report.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

We have not experienced any material changes in our market risk exposures since December 26, 2024.

**Item 4. Controls and Procedures**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.<u>Evaluation of disclosure controls and procedures</u>

Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the "Exchange Act")) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.<u>Changes in internal control over financial reporting</u>

There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

**PART II – OTHER INFORMATION**

**Item 1A. Risk Factors**

There have been no material changes from the risk factors disclosed in the Company's Annual Report on Form 10-K for the year ended December 26, 2024, except for the addition of, and the revision to, the risk factors set forth below, respectively:

***Tariffs that are implemented or merely threatened may increase the cost of commodities we purchase for use in our hotels, restaurants or theatres or the cost of production for films released in our theatres.***

The federal government may threaten or implement tariffs on other countries that supply commodities we purchase for use in our hotels, restaurants or theatres or on countries in which films are produced or filmed. The tariffs themselves could have the impact of increasing the aggregate purchase cost of the same products, reducing the supply of available products or raise the cost of showing films in our theatres. Additionally, these tariffs may result in retaliation by the affected countries, leading to trade wars with an unpredictable result. We may not be able to offset increased cost through room rate, menu or ticket price increases, and even if we were to increase room rate, menu or ticket prices to cover some or all of the increased cost, such action could lead to decreased traffic to our hotels, restaurants or theatres which would negatively affect our financial results.

***The lack of both the quantity and audience appeal of motion pictures may adversely affect our financial results.***

The financial results of our movie theatre business and the motion picture industry in general are heavily dependent on the general audience appeal of available films, together with studio marketing, advertising and support campaigns, factors over which we have no control. The relative success of our movie theatre business will continue to be largely dependent upon the quantity and audience appeal of films made available by the movie studios and other producers. Poor performance of films, a disruption in the production of films due to events such as tariffs or threatened tariffs, a strike by actors, writers or directors, or a reduction in the marketing efforts of the film distributors to promote their films could have an adverse impact on our business and results of operations. Our industry experienced a significant reduction in the quantity of films available to exhibit in theatres in the years following the COVID-19 pandemic. The quantity of new film releases available for theatrical exhibition during fiscal 2023 and fiscal 2024 was negatively impacted by the shutdown of movie production during the WGA and SAG-AFTRA labor strikes that occurred during fiscal 2023. Studios may also determine that certain types of films will not be released for theatrical exhibition and will go straight to streaming services, further impacting the quantity of films available. Also, our quarterly results of operations are significantly dependent on the quantity and audience appeal of films that we exhibit during each quarter. As a result, our quarterly results may be unpredictable and somewhat volatile.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of <br>Shares <br>Purchased** | **Average Price <br>Paid per Share** | **Total Number of <br>Shares <br>Purchased as <br>Part of Publicly <br>Announced <br>Programs (1)** | **Maximum <br>Number of <br>Shares that May <br>Yet be Purchased <br>Under the Plans <br>or Programs (1)** |
| April 1 - April 30 |  | $— |  | 1262090 |
| May 1 - May 31 |  |  |  | 1262090 |
| June 1 - June 30 |  |  |  | 1262090 |
| **Total** |  | $— |  | 1262090 |

---

(1)Through June 30, 2025, our Board of Directors had authorized the repurchase of up to approximately 11.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of June 30, 2025, we had repurchased approximately 10.4 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit,

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

During the three months ended June 30, 2025, no director or Section 16 officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| 10.1 | <u>[The Marcus Corporation 2025 Omnibus Incentive Plan](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[\[](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[I](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[ncorporated by reference](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[to](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[Exhibit 10.1 to our Current Report on Form 8-K, dated May 12, 202](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[5](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[\]](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)[.](https://www.sec.gov/Archives/edgar/data/62234/000006223425000028/mcs-20250506x8kxex101.htm)</u> |
| 31.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mcs-20250630x10qxex311.htm)</u> |
| 31.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mcs-20250630x10qxex312.htm)</u> |
| 32 | <u>[Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.](mcs-20250630x10qxex32.htm)</u> |
| 101.INS | The instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

<u>[**Table of Contents**](#ie4db6407dc034a498daea3bed427a42e_7)</u> 

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| <u>THE MARCUS CORPORATION</u> | <u>THE MARCUS CORPORATION</u> | <u>THE MARCUS CORPORATION</u> |
| DATE: August 1, 2025 | By: | /s/ Gregory S. Marcus |
|  |  | Gregory S. Marcus |
|  |  | President and Chief Executive Officer |
| DATE: August 1, 2025 | By: | /s/ Chad M. Paris |
|  |  | Chad M. Paris |
|  |  | Chief Financial Officer and Treasurer |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Chief Executive Officer**

**Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)**

**or 15d-14(a) under the Securities Exchange Act of 1934**

I, Gregory S. Marcus, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| DATE: August 1, 2025 | By: | /s/ Gregory S. Marcus |
|  |  | Gregory S. Marcus |
|  |  | President and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification of Chief Financial Officer**

**Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)**

**or 15d-14(a) under the Securities Exchange Act of 1934**

I, Chad M. Paris, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| DATE: August 1, 2025 | By: | /s/ Chad M. Paris |
|  |  | Chad M. Paris |
|  |  | Chief Financial Officer and Treasurer |

---

## Ex-32

**Exhibit 32**

**Written Statement of the Chief Executive Officer and Chief Financial Officer**

**Pursuant to 18 U.S.C. §1350**

Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of The Marcus Corporation (the "Company"), hereby certify, based on our knowledge, that the accompanying Quarterly Report on Form 10-Q of the Company (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| /s/ Gregory S. Marcus | /s/ Gregory S. Marcus |
| Gregory S. Marcus | Gregory S. Marcus |
| President and Chief Executive Officer | President and Chief Executive Officer |
| /s/ Chad M. Paris | /s/ Chad M. Paris |
| Chad M. Paris | Chad M. Paris |
| Chief Financial Officer and Treasurer | Chief Financial Officer and Treasurer |
| Date: | August 1, 2025 |

---

<br>